PMID- 23297114 OWN - NLM STAT- MEDLINE DCOM- 20131029 LR - 20161125 IS - 1097-4644 (Electronic) IS - 0730-2312 (Linking) VI - 114 IP - 7 DP - 2013 Jul TI - Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-alpha activation. PG - 1536-48 LID - 10.1002/jcb.24495 [doi] AB - H2S is the third endogenous gaseous mediator, after nitric oxide and carbon monoxide, possessing pleiotropic effects, including cytoprotection and anti-inflammatory action. We analyzed, in an in vitro model entailing monocyte adhesion to an endothelial monolayer, the changes induced by H2S on various potential targets, including cytokines, chemokines, and proteases, playing a crucial role in inflammation and cell adhesion. Results show that H2S prevents the increase in monocyte adhesion induced by tumor necrosis factor-alpha (TNF-alpha). Under these conditions, downregulation of monocyte chemoattractant protein-1 (MCP-1), chemokine C-C motif receptor 2, and increase of cluster of differentiation 36 could be detected in monocytes. In endothelial cells, H2 S treatment reduces the increase in MCP-1, inter-cellular adhesion molecule-1, vascular cell adhesion molecule-1, and of a disintegrin and metalloproteinase metallopeptidase domain 17 (ADAM17), both at the gene expression and protein levels. Cystathionine gamma-lyase and 3-mercaptopyruvate sulfurtransferase, the major H2S forming enzymes, are downregulated in endothelial cells. In addition, H2S significantly reduces activation of ADAM17 by PMA in endothelial cells, with consequent reduction of both ADAM17-dependent TNF-alpha ectodomain shedding and MCP-1 release. In conclusion, H2S is able to prevent endothelial activation by hampering endothelial activation, triggered by TNF-alpha. The mechanism of this protective effect is mainly mediated by down-modulation of ADAM17-dependent TNF-converting enzyme (TACE) activity with consequent inhibition of soluble TNF-alpha shedding and its relevant MCP-1 release in the medium. These results are discussed in the light of the potential protective role of H2S in pro-inflammatory and pro-atherogenic processes, such as chronic renal failure. CI - Copyright (c) 2013 Wiley Periodicals, Inc. FAU - Perna, Alessandra F AU - Perna AF AD - First Division of Nephrology, Department of Cardio-thoracic and Respiratory Sciences, Second University of Naples, School of Medicine and Surgery, Naples, Italy. alessandra.perna@unina2.it FAU - Sepe, Immacolata AU - Sepe I FAU - Lanza, Diana AU - Lanza D FAU - Capasso, Rosanna AU - Capasso R FAU - Zappavigna, Silvia AU - Zappavigna S FAU - Capasso, Giovambattista AU - Capasso G FAU - Caraglia, Michele AU - Caraglia M FAU - Ingrosso, Diego AU - Ingrosso D LA - eng PT - Journal Article PL - United States TA - J Cell Biochem JT - Journal of cellular biochemistry JID - 8205768 RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 3.4.24.- (ADAM Proteins) RN - EC 3.4.24.86 (ADAM17 Protein) RN - EC 3.4.24.86 (ADAM17 protein, human) RN - YY9FVM7NSN (Hydrogen Sulfide) SB - IM MH - ADAM Proteins/genetics/*metabolism MH - ADAM17 Protein MH - Blotting, Western MH - Cell Adhesion/*drug effects MH - Cell Line MH - Enzyme-Linked Immunosorbent Assay MH - Flow Cytometry MH - Humans MH - Hydrogen Sulfide/*pharmacology MH - Inflammation/*metabolism MH - Polymerase Chain Reaction MH - Tumor Necrosis Factor-alpha/*metabolism EDAT- 2013/01/09 06:00 MHDA- 2013/10/30 06:00 CRDT- 2013/01/09 06:00 PHST- 2012/09/28 00:00 [received] PHST- 2012/12/18 00:00 [accepted] PHST- 2013/01/09 06:00 [entrez] PHST- 2013/01/09 06:00 [pubmed] PHST- 2013/10/30 06:00 [medline] AID - 10.1002/jcb.24495 [doi] PST - ppublish SO - J Cell Biochem. 2013 Jul;114(7):1536-48. doi: 10.1002/jcb.24495.